Unveiling Australia’s fastest next-gen mpox diagnostic tool

In a collaborative study published in The Lancet Microbe, a team of scientists, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and WEHI (Walter and Eliza Hall Institute of Medical Research), revealed MPXV-CRISPR—a powerful diagnostic tool capable of detecting monkeypox virus (MPXV) in clinical samples with acute precision and at a faster rate than any other method, thanks to the power of CRISPR technology. It is the first CRISPR-based diagnostic method in Australia specifically designed to target genetic sequences found only in MPXV.